Open access

Impact of cardiovascular risk enrichment on incidence of major adverse cardiovascular events in the tofacitinib rheumatoid arthritis clinical programme
Maxime Dougados, Christina Charles-Schoeman, Zoltán Szekanecz, Jon T Giles, Steven R Ytterberg, Deepak L Bhatt, Gary G Koch, Ivana Vranic, Joseph Wu, Cunshan Wang, Kenneth Kwok, Sujatha Menon, Carol A Connell, Arne Yndestad, Jose L Rivas, Maya H Buch

Annals of the Rheumatic Diseases Jan 2023, ard-2022-223406; DOI: 10.1136/ard-2022-223406
Combined therapy of prednisone and mTOR inhibitor sirolimus for treating retroperitoneal fibrosis
Hui Gao, Shibo Liu, Yuanbang Mai, Yuying Wang, Xuewu Zhang, Shufen Zheng, Chenghua Luo, Cuiping Pan

Annals of the Rheumatic Diseases Jan 2023, ard-2022-223736; DOI: 10.1136/ard-2022-223736
Long-term effectiveness and persistence of ustekinumab and TNF inhibitors in patients with psoriatic arthritis: final 3-year results from the PsABio real-world study
Laure Gossec, Stefan Siebert, Paul Bergmans, Kurt de Vlam, Elisa Gremese, Beatriz Joven-Ibáñez, Tatiana V Korotaeva, Frederic Lavie, Wim Noël, Michael T Nurmohamed, Petros P Sfikakis, Mohamed Sharaf, Elke Theander, Josef S Smolen

Annals of the Rheumatic Diseases Dec 2022, annrheumdis-2022-222879; DOI: 10.1136/ard-2022-222879
Risk factors for serious infections in ANCA-associated vasculitis
Balazs Odler, Regina Riedl, Philipp Gauckler, Jae Il Shin, Johannes Leierer, Peter A Merkel, William St. Clair, Fernando Fervenza, Duvuru Geetha, Paul Monach, David Jayne, Rona M Smith, Alexander Rosenkranz, Ulrich Specks, John H Stone, Andreas Kronbichler

Annals of the Rheumatic Diseases Jan 2023, ard-2022-223401; DOI: 10.1136/ard-2022-223401
Lupus low disease activity state attainment in the phase 3 TULIP trials of anifrolumab in active systemic lupus erythematosus
Eric F Morand, Gabriel Abreu, Richard A Furie, Vera Golder, Raj Tummala

Annals of the Rheumatic Diseases Jan 2023, annrheumdis-2022-222748; DOI: 10.1136/ard-2022-222748
Venous thromboembolism with JAK inhibitors and other immune-modulatory drugs: a Swedish comparative safety study among patients with rheumatoid arthritis
Viktor Molander, Hannah Bower, Thomas Frisell, Benedicte Delcoigne, Daniela Di Giuseppe, Johan Askling

Annals of the Rheumatic Diseases Feb 2023, 82 (2) 189-197; DOI: 10.1136/ard-2022-223050
PU.1 promotes development of rheumatoid arthritis via repressing FLT3 in macrophages and fibroblast-like synoviocytes
Jiajie Tu, Weile Chen, Yilong Fang, Dafei Han, Yizhao Chen, Haifeng Jiang, Xuewen Tan, Zhen Xu, Xuming Wu, Huihui Wang, Xiangling Zhu, Wenming Hong, Zhenbao Li, Chen Zhu, Xinming Wang, Wei Wei

Annals of the Rheumatic Diseases Feb 2023, 82 (2) 198-211; DOI: 10.1136/ard-2022-222708
Recapture and retreatment rates with ixekizumab after withdrawal of therapy in patients with axial spondyloarthritis: results at week 104 from a randomised placebo-controlled withdrawal study
Robert B M Landewé, Denis Poddubnyy, Proton Rahman, Filip E Van den Bosch, Rebecca Bolce, Soyi Liu Leage, Jeffrey R Lisse, So Young Park, Lianne Gensler

Annals of the Rheumatic Diseases Feb 2023, 82 (2) 212-216; DOI: 10.1136/ard-2022-222731
Belimumab use during pregnancy: a summary of birth defects and pregnancy loss from belimumab clinical trials, a pregnancy registry and postmarketing reports
Michelle Petri, Helain Landy, Megan E B Clowse, Kim Gemzoe, Munther Khamashta, Milena Kurtinecz, Roger A Levy, Andrew Liu, Rebecca Marino, Paige Meizlik, Jeanne M Pimenta, Kelsey Sumner, Hugh Tilson, Mary Beth Connolly, Keele Wurst, Julia Harris, Holly Quasny, Patricia Juliao, David A Roth

Annals of the Rheumatic Diseases Feb 2023, 82 (2) 217-225; DOI: 10.1136/ard-2022-222505
3D genome alterations in T cells associated with disease activity of systemic lupus erythematosus
Ming Zhao, Delong Feng, Longyuan Hu, Lin Liu, Jiali Wu, Zhi Hu, Haojun Long, Qiqi Kuang, Lianlian Ouyang, Qianjin Lu

Annals of the Rheumatic Diseases Feb 2023, 82 (2) 226-234; DOI: 10.1136/ard-2022-222653

Main menu

Open access

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Open access

Pages